| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 21,128,242 | 22,199,890 | 17,533,263 | | Cost of Revenue | 12,498,080 | 12,922,620 | 10,224,737 | | | Gross Profit | 8,630,162 | 9,277,270 | 7,308,526 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 7,877,273 | 7,462,210 | 5,830,729 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 752,889 | 1,815,060 | 1,477,797 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (381,152) | (20,020) | 63,466 | | Earnings Before Interest And Taxes | 371,737 | 1,795,040 | 1,541,263 | | Interest Expense | 59,222 | 48,350 | 62,288 | | Income Before Tax | 312,515 | 1,746,690 | 1,478,975 | | Income Tax Expense | 223,818 | 633,960 | 545,136 | | Minority Interest | (23,454) | (60,570) | (46,678) | | | | Net Income From Continuing Ops | 65,960 | 1,064,630 | 900,203 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 46,611 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 65,960 | 1,064,630 | 946,814 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $65,960 | $1,064,630 | $946,814 |
|
1.00% Nasdaq 
0.25 (0.36%) 
Income Statement
